000 | 01775 a2200481 4500 | ||
---|---|---|---|
005 | 20250515135947.0 | ||
264 | 0 | _c20081216 | |
008 | 200812s 0 0 eng d | ||
022 | _a1521-0111 | ||
024 | 7 |
_a10.1124/mol.108.050104 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHasinoff, Brian B | |
245 | 0 | 0 |
_aMechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib. _h[electronic resource] |
260 |
_bMolecular pharmacology _cDec 2008 |
||
300 |
_a1722-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aAcetyl-CoA Carboxylase _xmetabolism |
650 | 0 | 4 |
_aAdenosine Triphosphate _xbiosynthesis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Newborn |
650 | 0 | 4 |
_aAntineoplastic Agents _xtoxicity |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 |
_aIndoles _xtoxicity |
650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
650 | 0 | 4 |
_aMetformin _xpharmacology |
650 | 0 | 4 |
_aMuscle Cells _xdrug effects |
650 | 0 | 4 | _aOxidative Stress |
650 | 0 | 4 |
_aPhenformin _xpharmacology |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aPyrroles _xtoxicity |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aRibosomal Protein S6 Kinases, 90-kDa _xantagonists & inhibitors |
650 | 0 | 4 | _aSunitinib |
700 | 1 | _aPatel, Daywin | |
700 | 1 | _aO'Hara, Kimberley A | |
773 | 0 |
_tMolecular pharmacology _gvol. 74 _gno. 6 _gp. 1722-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.108.050104 _zAvailable from publisher's website |
999 |
_c18282429 _d18282429 |